Salvage surgery and radiotherapy including intraoperative electron radiotherapy in isolated locally recurrent tumors: Predictors of outcome. Issue 2 (August 2015)
- Record Type:
- Journal Article
- Title:
- Salvage surgery and radiotherapy including intraoperative electron radiotherapy in isolated locally recurrent tumors: Predictors of outcome. Issue 2 (August 2015)
- Main Title:
- Salvage surgery and radiotherapy including intraoperative electron radiotherapy in isolated locally recurrent tumors: Predictors of outcome
- Authors:
- Cambeiro, Mauricio
Calvo, Felipe A.
Aristu, José Javier
Jimenez, Marta Moreno
San-Julian, Mikel
Alcalde, Juan
Hernandez-Lizoain, Jose Luis
Jurado, Matías
Martínez-Monge, Rafael - Abstract:
- <abstract xml:lang="en" abstract-type="author" id="ab005"> <title id="st005">Abstract</title> <sec> <title id="st010">Purpose</title> <p id="sp0005">To evaluate the influence of equivalent dose (EQD2) in clinical outcomes of patients with isolated locally recurrent tumors (ILRT), treated with salvage surgery and intra-operative electron beam radiation therapy (IOERT).</p> </sec> <sec> <title id="st015">Methods and materials</title> <p id="sp0010">We retrospectively reviewed 128 patients with non-metastatic ILRT of different tissues (soft tissue sarcomas, head and neck, uterine, and colorectal). Patients had received salvage surgery (R0/R1/R2) and IOERT. Previously not irradiated patients had received additional external beam radiation therapy (EBRT).</p> </sec> <sec> <title id="st020">Results</title> <p id="sp0015">IOERT was delivered at a median dose of 15 Gy (range, 5–25 Gy). Seventy-five patients (60.9%) received additional EBRT of 46 Gy.</p> <p id="sp0020">Median EQD2 of salvage program was 62 Gy and median EQD2 of exclusive IORT was 31.2 Gy. Median follow-up was 19.2 months (range: 1.3–220). Thirty-one patients (24.2%) developed severe (grade 3–5) complications. New locoregional recurrence was documented in 86 (67.2%) of the 123 cases. Five-year rates were 31% for locoregional control, 57% for distant metastasis-free and 31% for overall survival. On multivariate analysis, R0–1 vs. R2 resection (HR 2.2, 95 CI: 1.2–4.1) was statistically significant for locoregional<abstract xml:lang="en" abstract-type="author" id="ab005"> <title id="st005">Abstract</title> <sec> <title id="st010">Purpose</title> <p id="sp0005">To evaluate the influence of equivalent dose (EQD2) in clinical outcomes of patients with isolated locally recurrent tumors (ILRT), treated with salvage surgery and intra-operative electron beam radiation therapy (IOERT).</p> </sec> <sec> <title id="st015">Methods and materials</title> <p id="sp0010">We retrospectively reviewed 128 patients with non-metastatic ILRT of different tissues (soft tissue sarcomas, head and neck, uterine, and colorectal). Patients had received salvage surgery (R0/R1/R2) and IOERT. Previously not irradiated patients had received additional external beam radiation therapy (EBRT).</p> </sec> <sec> <title id="st020">Results</title> <p id="sp0015">IOERT was delivered at a median dose of 15 Gy (range, 5–25 Gy). Seventy-five patients (60.9%) received additional EBRT of 46 Gy.</p> <p id="sp0020">Median EQD2 of salvage program was 62 Gy and median EQD2 of exclusive IORT was 31.2 Gy. Median follow-up was 19.2 months (range: 1.3–220). Thirty-one patients (24.2%) developed severe (grade 3–5) complications. New locoregional recurrence was documented in 86 (67.2%) of the 123 cases. Five-year rates were 31% for locoregional control, 57% for distant metastasis-free and 31% for overall survival. On multivariate analysis, R0–1 vs. R2 resection (HR 2.2, 95 CI: 1.2–4.1) was statistically significant for locoregional recurrence and EQD2 ⩾62 Gy for survival (HR 2.2, 95 CI: 1.1–4.1).</p> </sec> <sec> <title id="st025">Conclusions</title> <p id="sp0025">Surgical radicality (gross macroscopic resection) and radiation dose (EQD2 ⩾62 Gy in radiation salvage program) are the dominant prognostic factors beside ILRT histology. Modest rates of long-term disease control are expected when both factors are fulfilled.</p> </sec> </abstract> … (more)
- Is Part Of:
- Radiotherapy and oncology. Volume 116:Issue 2(2015:Aug.)
- Journal:
- Radiotherapy and oncology
- Issue:
- Volume 116:Issue 2(2015:Aug.)
- Issue Display:
- Volume 116, Issue 2 (2015)
- Year:
- 2015
- Volume:
- 116
- Issue:
- 2
- Issue Sort Value:
- 2015-0116-0002-0000
- Page Start:
- 316
- Page End:
- 322
- Publication Date:
- 2015-08
- Subjects:
- Oncology -- Periodicals
Radiotherapy -- Periodicals
Tumors -- Periodicals
Medical Oncology -- Periodicals
Neoplasms -- radiotherapy -- Periodicals
Radiotherapy -- Periodicals
Radiothérapie -- Périodiques
Cancérologie -- Périodiques
Tumeurs -- Périodiques
Electronic journals
616.9940642 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01678140 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01678140 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01678140 ↗
http://www.estro.org/ ↗
http://www.elsevier.com/journals ↗
http://www.journals.elsevier.com/radiotherapy-and-oncology/ ↗ - DOI:
- 10.1016/j.radonc.2015.07.009 ↗
- Languages:
- English
- ISSNs:
- 0167-8140
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7240.790000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3936.xml